Oragenics, Inc.
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 28 Aug 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 21 Oct 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Oragenics, Inc. — Overview & Financial Snapshot
Oragenics, Inc. (NYSE American: OGEN) is a Healthcare company, ranked #3,407 of 6,774 companies globally and #1,448 of 4,000 in United States on PositoAI, with a Positivity Score of 20,589. Its market capitalisation is ₹17.26 Cr ($1.83M), P/E ratio is -0.2 and P/B ratio is 0.30. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.
For financial statements, ratio trends and score history, Go Deep →